Can dolutegravir dual therapy or monotherapy produce and maintain HIV suppression?
The majority of migrants living with HIV in Europe may have acquired HIV in their new country
Benefits of early HIV treatment are clear, but issues raised by START and D:A:D remain unresolved
Needle and syringe exchanges need to adapt to meet the needs of people who inject steroids and image-enhancing drugs
Newest MDR-TB drug prices could fall by up to 95% through generic production
TB death rate four times higher in Eastern Europe due to lack of HIV treatment after TB diagnosis
Three-month isoniazid/pyrazinamide regimen prevents TB as well as 6-month isoniazid in people living with HIV
Can Europe reach the 90-90-90 target for HIV treatment by 2020?
Modest bone loss seen in young men taking Truvada for pre-exposure prophylaxis
